Total Payments
$10,959
2022 Payments
$1,120
Companies
19
Transactions
601
Medicare Patients
289
Medicare Billing
$81,066
Payment Breakdown by Category
Food & Beverage$10,959 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,959 | 601 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $2,219 | 163 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $1,721 | 80 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $1,252 | 51 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,144 | 55 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $1,073 | 44 | $0 (2022) |
| ITI, Inc. | $808.02 | 46 | $0 (2022) |
| Lundbeck LLC | $755.42 | 46 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $373.57 | 19 | $0 (2021) |
| Shire North American Group Inc | $323.12 | 20 | $0 (2019) |
| EISAI INC. | $318.91 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,120 | 50 | ITI, Inc. ($203.65) |
| 2021 | $2,372 | 112 | ITI, Inc. ($418.65) |
| 2020 | $1,777 | 87 | Vanda Pharmaceuticals Inc. ($354.51) |
| 2019 | $2,202 | 130 | Sunovion Pharmaceuticals Inc. ($689.58) |
| 2018 | $1,957 | 121 | Sunovion Pharmaceuticals Inc. ($625.13) |
| 2017 | $1,531 | 101 | Sunovion Pharmaceuticals Inc. ($694.71) |
All Payment Transactions
601 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Neuropsychiatry | ||||||
| 07/19/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Neuropsychiatry | ||||||
| 07/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: CNS | ||||||
| 06/21/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 06/09/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: Neuropsychiatry | ||||||
| 06/02/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: CNS | ||||||
| 05/26/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: PSYCHIATRY | ||||||
| 05/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: PSYCHIATRY | ||||||
| 05/20/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Neuropsychiatry | ||||||
| 05/11/2022 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: SCHIZOPHRENIA | ||||||
| 05/10/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: PSYCHIATRY | ||||||
| 05/05/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: CNS | ||||||
| 04/26/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: PSYCHIATRY | ||||||
| 04/21/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Neuropsychiatry | ||||||
| 04/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: PSYCHIATRY | ||||||
| 04/07/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 04/06/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: PSYCHIATRY | ||||||
| 03/29/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Neuropsychiatry | ||||||
| 03/22/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.62 | General |
| Category: PSYCHIATRY | ||||||
| 03/17/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 63 | 190 | $29,174 | $14,944 |
| 2021 | 2 | 92 | 383 | $48,761 | $33,757 |
| 2020 | 2 | 134 | 448 | $67,964 | $32,365 |
Total Patients
289
Total Services
1,021
Medicare Billing
$81,066
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 151 | $24,160 | $13,258 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 39 | $5,014 | $1,686 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 313 | $42,011 | $29,258 | 69.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 70 | $6,750 | $4,499 | 66.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 326 | $52,160 | $27,030 | 51.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 63 | 122 | $15,804 | $5,335 | 33.8% |
About Dr. Elliot Gruen, DO
Dr. Elliot Gruen, DO is a Psychiatry healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295760106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elliot Gruen, DO has received a total of $10,959 in payments from pharmaceutical and medical device companies, with $1,120 received in 2022. These payments were reported across 601 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($10,959).
As a Medicare-enrolled provider, Gruen has provided services to 289 Medicare beneficiaries, totaling 1,021 services with total Medicare billing of $81,066. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Lewiston, ME
- Active Since 07/11/2006
- Last Updated 02/25/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1295760106
Products in Payments
- LATUDA (Drug) $2,219
- REXULTI (Drug) $1,698
- INGREZZA (Drug) $1,073
- TRINTELLIX (Drug) $906.26
- CAPLYTA (Drug) $808.02
- HETLIOZ (Drug) $739.76
- Trintellix (Drug) $719.25
- ABILIFY MAINTENA (Drug) $485.86
- VRAYLAR (Drug) $350.27
- Dayvigo (Drug) $318.91
- Fanapt (Drug) $286.66
- VYVANSE (Drug) $218.42
- SPRAVATO (Drug) $217.68
- FANAPT (Drug) $165.65
- INVEGA SUSTENNA (Drug) $155.89
- ARISTADA (Drug) $141.06
- NUEDEXTA (Drug) $83.53
- BELSOMRA (Drug) $67.24
- MYDAYIS (Drug) $66.75
- BRINTELLIX (Drug) $63.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lewiston
Alfred Belen, Md, MD
Psychiatry — Payments: $8,587
Psychiatry $8,587
Dr. Thomas Holmes, M.d, M.D
Psychiatry — Payments: $8,178
Psychiatry $8,178
Brigitte Hristea, Md, MD
Psychiatry — Payments: $1,029
Psychiatry $1,029
Jennifer Mogul, Md, MD
Psychiatry — Payments: $95.01
Psychiatry $95.01
Dylan Mckenney, Md, MD
Psychiatry — Payments: $57.80
Psychiatry $57.80
Dr. Paula Kirby-Long, M.d, M.D
Psychiatry — Payments: $21.84
Psychiatry $21.84